Screening and diagnosis of breast cancer in augmented women

Breast Cancer

Volumn 15, Issue 2, 2008, Pages 159-164

  Uematsu, Takayoshi ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Augmented women; Breast cancer; Breast implant; Diagnosis; Screening

Indexed keywords

BREAST ENDOPROSTHESIS; BREAST SELF EXAMINATION; BREAST TUMOR; CANCER DIAGNOSIS; ECHOMAMMOGRAPHY; FEMALE; HUMAN; MAMMOGRAPHY; MASS SCREENING; REVIEW; RUPTURE;

BREAST IMPLANTS; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; RUPTURE; ULTRASONOGRAPHY, MAMMARY;

EID: 58949091150     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-008-0036-1     Document Type: Review

References (39)

1. American Society for Aesthetic Plastic Surgery. The American Society for Aesthetic Plastic Surgery 2004 Cosmetic Surgery National Data Bank Statistics. New York: American Society for Aesthetic Plastic Surgery, 2005.
2. Iinuma TJ. Time trend on the incidence risk of breast cancer among Japanese women-comparison between US and Japan. (in Japanese). Jpn Assoc Breast Cancer Screen. 2006;15:462.
3. Silverstein MJ, Handel N, Gamagami P. The effect of siliconegel- filled implants on mammography. Cancer. 1991;68:1159-63.
4. Handel N, Silverstein MJ, Gamagami P, Jensen JA, Collins A. Factors affecting mammographic visualization of the breast after augmentation mammaplasty. JAMA. 1992;268:1913-7.
5. Skinner KA, Silberman H, Dougherty W et al. Breast cancer after augmentation mammoplasty. Ann Surg Oncol. 2001;8: 138-44. (Pubitemid 32199410)
6. Handel N, Silverstein MJ. Breast cancer diagnosis and prognosis in augmented women. Plast Reconstr Surg. 2006;118:587-93. (Pubitemid 44318913)
7. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17): 1784-92. (Pubitemid 41549890)
8. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137:347-60. (Pubitemid 34977137)
9. Morimoto T, Okazaki M, Endo T. Current status and goals of mammographic screening for breast cancer in Japan. Breast Cancer. 2004;11:73-81.
10. Ohnuki K. Mammographic screening for non-palpable breast cancer in Japan. Breast Cancer. 2005;12:258-66.
11. Dershaw DD, Chaglassian TA. Mammography after prosthesis placement for augmentation or reconstructive mammoplasty. Radiology. 1989;170:69-74. (Pubitemid 19016848)
12. Leibman AJ, Kruse B. Breast cancer: mammographic and sonographic findings after augmentation mammoplasty. Radiology. 1990;174:195-8. (Pubitemid 20017109)
13. Eklund GW, Busby RC, Miller SH, Job JS. Improved imaging of the augmented breast. AJR Am J Roentgenol. 1988;151:469-73.
14. Fajardo LL, Harvey JA, McAleese KA, Roberts CC, Granstrom P. Breast cancer diagnosis in women with subglandular silicone gel filled augmentation implants. Radiology. 1995;194:859-62.
15. Holland R, Hendriks JHCL, Mravunac M. Mammographically occult breast cancer. Cancer. 1983;52:1810-9.
16. Miglioretti DL, Rutter CM, Geller BM, Cutter G, Barlow WE, Rosenberg R, Weaver DL, Taplin SH, Ballard-Barbash R, Carney PA, Yankaskas BC, Kerlikowske K. Effect of breast augmentation on the accuracy of mammography and cancer characteristics. JAMA. 2004;28:442-50. (Pubitemid 38129748)
17. Smathers RL, Boone JM, Lee LJ, Berns EA, Miller RA, Wright AM. Radiation dose reduction for augmentation mammography. AJR Am J Roentgenol. 2007;188:1414-21. (Pubitemid 46668528)
18. Brown SL, Silverman BG, Berg WA. Rupture of silicone-gel breast implants: causes, sequelae, and diagnosis. Lancet. 1997;350:1531-7. (Pubitemid 28036566)
19. Brown SL, Todd JF, Luu HM. Breast implant adverse events during mammography: reports to the Food and Drug Administration. J Womens Health. 2004;13:371-80.
20. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165-75.
21. Kaplan SS. Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue. Radiology. 2001;221:641-9. (Pubitemid 33101754)
22. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology. 1998;207:191-9.
23. Gordon PB, Goldenberg SL. Malignant breast masses detected only by ultrasound: a retrospective review. Cancer. 1995;76:626-30.
24. Hou MF, Ou-Yang F, Chuang CH, Wang JY, Lee LW, Huang YS, Huang CJ, Hsieh JS, Lai CS, Lin SD, Huang TJ. Comparison between sonography and mammography for breast cancer diagnosis in oriental women after augmentation mammoplasty. Ann Plast Surg. 2002;49:120-6. (Pubitemid 34848074)
25. Liberman L. Breast cancer screening with MRI-what are the data for patients at high risk? N Eng J Med. 2004;351:497-500. (Pubitemid 38988600)
26. Huch RA, Kunzi W, Debatin JF, Wiesner W, Krestin GP. MR imaging of the augmented breast. Eur Radiol. 1998;8:371-6. (Pubitemid 128546240)
27. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220: 13-30. (Pubitemid 32577955)
28. Kriege M, Brekelmans C, Boetes C, Besnard P, Zonderland H, Obdeijn IM, Manoliu R, Kok T, Peterse H, Tilanus-Linthorst M, Muller S, Meijer S, Oosterwijk J, Beex L, Tollenaar R, Koning H, Rutgers E, Klijn J. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Eng J Med. 2004;351:427-37.
29. Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer. 2005;103:1898-905. (Pubitemid 40563263)
30. Jinde L, Jianliang S, Xiaoping C, Xiaoyan T, Jiaqing L, Qun M, Bo L. Anatomy and clinical significance of pectoral fascia. Plast Reconstr Surg. 2006;118:1557-60. (Pubitemid 44747980)
31. Zahavi A, Sklair ML, Ad-El DD. Capsular contracture of the breast. Working towards a better classification using clinical and radiologic assessment. Ann Plast Surg. 2006;57:248-51. (Pubitemid 44318985)
32. Liberman L. Percutaneous imaging-guided core breast biopsy: state of the art at the millennium. AJR Am J Roentgenol. 2000;174:1191-9.
33. Jackman RJ, Lamm RL. Stereotactic histologic biopsy in breasts with implants. Radiology. 2002;222:157-64. (Pubitemid 34031482)
34. Fornage BF, Sneige N, Singletary SE. Masses in breast with implants: diagnosis with US-guided fine-needle aspiration biopsy. Radiology. 1994;191:339-42. (Pubitemid 24141030)
35. Lannin DR, Ponn T, Andrejeva L, Philpotts L. Should all breast cancers be diagnosed by needle biopsy? Am J Surg. 2006;192:450-4. (Pubitemid 44344201)
36. Monstrey S, Delanghe J, Christophe A, Dhooge W, de Greyt W, Bernarad D, van Landuyt K, Blondeel P. Biocompatibility and oxidative stability of radiolucent breast implants. Plast Reconstr Surg. 2000;105:1429-34. (Pubitemid 30169478)
37. Monstrey S, Christophe A, Delanghe J, Vriese SD, Hamdi M, van Landuyt K, Blondeel P. What exactly was wrong with the trilucent breast implants? A unifying hypothesis. Plast Reconstr Surg. 2004;113:847-56. (Pubitemid 39195742)
38. Scuderi N, Mazzocchi M, Alfano C, Onesti MG. Prospective study on trilucent soybean oil-filled breast prosthesis. Plast Reconstr Surg. 2005;116:1130-6. (Pubitemid 41324941)
39. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA. 2005;293:1245-56. (Pubitemid 40327910)